In New Zealand, advertisements are not independently evaluated for the quality and validity of scientific statements unless someone complains, 8 and this system has not prevented misleading advertisements. 9 Even in the United States, which has mostly privately-funded healthcare 7 and DTCA is regulated and overseen by the Food and Drug Administration, violations by pharmaceutical companies are prevalent, predominantly for providing misleading information. [10] [11] [12] [13] DTCA both benefits and harms public health. [14] [15] [16] Given that some medications are underused and some are overused, DTCA that increases prescribing may have positive or negative effects. 16 DTCA can have positive outcomes when the disease to be treated is severe and the medicine is safe, effective and underused; whereas, when the condition is not serious and the medicine is potentially unsafe, less effective or overused, the effects of DTCA will be negative. 16 Supporters argue that DTCA can inform and empower the public and increase their autonomy by educating them about medical conditions and possible treatments. [17] [18] [19] However, even though DTCA may inform individuals, it may also mislead them. 14 Critics argue that DTCA is persuasive rather than informative because it presents partial and biased information that exaggerates the potential benefits of medicines. 17, [20] [21] [22] [23] DTCA has also been criticised for using 'scare-mongering' tactics to encourage patients to start a treatment. 24, 25 Past research shows DTCA leads to the advertised medicines being sought and requested by individuals. 12, 17, 26, 27 Of note, Lifestyle determinants of behavioural outcomes triggered by direct-to-consumer advertising of prescription medicines: a cross-sectional study studies reveal that when a message shows a medicine as very effective, individuals do not try to process the rest of the information presented in the message. 28 Doctors may face extra work and frustration if a patient discusses the medicine with them as a result of 'evidence' from an advertisement. 14, 28 Research also shows that when patients request a specific medicine; doctors usually prescribe it. 21, 29, 30 Further, advertising a medication as the solution to a health condition may cause audiences to think that healthy lifestyles, such as proper nutrition and exercise, are ineffective or needless. 31 Hence, the influence of medicine advertising on consumers with unhealthier lifestyle practices is of particular concern.
Research discusses that DTCA can change people's views on normal and medical conditions by encouraging the use of medicine to cure 'every ill' . 32, 33 Aspects of bodily experiences, which are normally reflections of individuals' lifestyles, have been medicalised by the pharmaceutical industry's efforts to find treatments for these 'new' illnesses. 34, 35 Lifestyle behaviours can affect both consumer behaviour 36 and consumer health. [37] [38] [39] [40] [41] [42] Lifestyle has been studied as a leading contributor to health outcomes by researchers. 43 Previous research has established that the study of lifestyle behaviours can provide more information about, and a better picture of, individuals than their demographics. 36 Lifestyle comprises people's daily behaviours, such as activities, fun and nutrition. 43 Health lifestyles are defined as health-related behaviours according to individuals' preferences from available options. 44 Unhealthy nutrition, physical inactivity, drug abuse, smoking, alcohol consumption and medicine abuse are common indicators of an unhealthy lifestyle. [41] [42] [43] 45 According to existing studies, engaging in one or more unhealthy lifestyle behaviours advances the risk of death. [46] [47] [48] [49] A meta-analysis revealed that having a healthy lifestyle is linked to a lower risk of death so that a mix of healthy lifestyle behaviours, such as not smoking, moderate alcohol drinking, healthy nutrition, regular physical activity, and having an optimal weight, was linked to a 66% decrease in mortality. 48 Furthermore, "demographic and socioeconomic factors are major determinants of health". 50 
Methods

Study sample
This exploratory study analysed data collected by an Australasian market research company through an online survey of 2,057 adults in New Zealand in 2013. A quota sampling method was used, capturing a nationally-representative sample of the New Zealand population, to allow for generalisability of the results. The survey had ethical approval from the University of Otago, and all participants gave their informed consent.
Variables and measures
The data used in this study came from a larger research project on consumer behaviour and lifestyle. In this study, measures and variables relevant to demographics, socioeconomics, lifestyle factors and behavioural responses to DTCA were explored.
Dependent variables
Self-reported behaviours in response to seeing an advertisement for a medicine 27 were measured by four yes/no questions adapted from prior studies: 'As a result of seeing an advertisement for a drug, have you asked your doctor for a prescription?'; 62 'As a result of seeing an advertisement for a drug, have you asked your doctor for more information about an illness?'; 62 
Results
Descriptive statistics
The demographics and socioeconomics of the sample are shown in Table 1 . 27 Table 2 shows the means and standard deviations for non-demographic independent variables.
Predictors of behavioural outcomes
Results of the multivariate binary logistic regression models predicting self-reported behavioural responses to DTCA are presented in Table 3 .
Asking a doctor for a prescription
Asking a doctor for a prescription was associated with older age (OR=1.01, 95%CI (Table 3) .
Asking a doctor for more information about an illness
Asking a doctor about an illness was associated with more illegal drug consumption (OR=1. An alternative explanation is that these unhealthy lifestyle behaviours and health inequalities may be caused by socioeconomic and cultural disparities. 52, [79] [80] [81] This is, however, the first study to reveal the association between lifestyle factors and behavioural responses to DTCA. The present findings extend existing research by showing that individuals who have a tendency towards poorer lifestyle choices, are more receptive to medicine advertising than those with healthier lifestyles. This association could be due to individuals with poorer lifestyle behaviours being more likely to have poorer health, 74, 75 and/or their desire to take a medicine rather than changing lifestyle behaviours.
The finding that individuals with less healthy lifestyles are more likely to be influenced by DTCA is of significant concern given that DTCA does not usually focus on public health issues such as nutrition, exercise, addictions and appropriate consumption of current medications. 16 Thus, DTCA can result in public pharmaceuticalisation, which leads to the use of lifestyle medicines (e.g. weight loss pills), perceived by individuals "as a 'magic bullet' to resolve problems of daily life". 82 (Table 3) .
Asking a pharmacist for more information about a drug
Asking a pharmacist for more information about an advertised drug was associated with older age (OR=1.02, 95%CI 17 research has shown that the main goal of medicine advertising is to persuade rather than to inform, and it has been successful at persuasion. 21, 22 Thus, the public needs to be informed that DTCA is a marketing tool, predominantly aimed at affecting prescribing behaviour, driving choice, and increasing profit.
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Limitations
The current findings were based on a crosssectional survey; thus, causal conclusions cannot be made. Moreover, the respondents' self-reported lifestyle behaviours, as well as self-reported behavioural responses to DTCA, might not reflect individuals' actual behaviours and might increase the possibility that certain behaviours were under or over reported. However, the anonymity assured by the online survey platform, a method that has strengths over traditional methods, 86 would have assisted truthful responses. 71 This study was exploratory research and included a large pool of potential predictors, which should be useful in guiding future, more confirmatory work. However, this issue can increase the chance of observing a Type I error. Moreover, since the data did not include tobacco use behaviours, future research could extend the current findings by exploring the relationship between smoking as an unhealthy lifestyle factor, and behavioural responses to medicine advertising.
Conclusions
While much attention has been paid to the effects of lifestyles on individuals' behaviour (e.g. buying behaviour), 36 and health inequalities, [37] [38] [39] [40] [41] [42] 45 to the best of our knowledge, no study has documented DTCA-triggered behavioural responses of individuals with less healthy lifestyle habits. This study primarily revealed that individuals with unhealthier lifestyles, that is, less physical activity, higher levels of alcohol consumption, unhealthier nutritional habits and higher levels of illegal drug use, were more likely to respond to DTCA. The negative attitude towards doing exercise also influenced asking a doctor for a prescription. Overall, these associations, along with previously reported findings 27 linking being a woman, increasing age, lower income, lower education and belonging to an ethnic minority suggest that these 'at risk' or 'disadvantaged' groups can be more susceptible towards DTCA and may not be able to make informed decisions. This raises concerns regarding the ethicality of DTCA in its current form, especially given that DTCA is self-regulated in New Zealand.
Implications
The findings of our large representative sample can be generalised to the national population in New Zealand and have important implications for both public health policy makers and pharmaceutical companies. Considering the findings of this study together with the outcomes of earlier studies regarding individuals' positive attitudes towards medicine advertising, 27 awareness on lifestyle changes should be supported through a combination of efforts to facilitate healthy behaviours. 87 Accordingly, based on our findings, we call for the pharmaceutical industry to stress healthy lifestyle behaviours as an alternative to taking medications, where applicable. Furthermore, pharmaceutical companies should not target 'at risk' individuals, position their products based on individuals' lifestyle characteristics and depict their product as a wonder drug. Instead, they need to make DTCA more ethical by explicitly and impartially stating that behavioural changes could be as effective as taking the advertised medicine. Communications on lifestyle changes in DTCA need to more specifically target those with unhealthy lifestyles. These actions can also benefit pharmaceutical companies since it is in the companies' lasting interest to advertise responsively, fairly and truthfully. 88 This study also highlights the need for interprofessional collaborations to educate individuals and convey the value of health behaviour changes to help 'disadvantaged' groups make more informed health-related decisions. Healthcare professionals thus can become "both gatekeepers and influencers over the purchase of the prescription medicine, and make the purchase not only a cognitive process, but also a social process". 89(p275) They can play an important role in educating and supporting peoples' health behaviour changes 90 as well as moderating the potential negative effects of DTCA and its persuasion process on individuals' decision making, consistent with consumer socialisation theory that highlights the influence of socialisation agents in consumers' decision-making process. 89, 91, 92 Since social and economic disparities can result in health behaviour and health inequalities, 51 health promotion policy should also consider social determinants in addition to motivating individual actions for changing unhealthy behaviours. 52 Previous research discussed that rules which may harm individuals' health should be changed. 93 In line with existing research, 94 the findings of this study suggest that the current rules on DTCA are not sufficient to protect consumers, and reinforce the need for tighter control and regulatory actions on DTCA. This study also proposes that the government should focus on increasing individuals' health literacy, monitor advertising of lifestyle medicines and ensure that DTCA is more beneficial than harmful, to help individuals make informed decisions. It is hoped that this controversial, but powerful, medium can be utilised to improve the wellbeing of society.
